CASE STUDY ON EBSTEIN’S ANOMALY AND THE VALUE OF CARDIAC MRI IN PREOPERATIVE DIAGNOSIS

Luong Quang Huy1, , Nguyen Thi Huyen2, Nguyen Ngoc Trang2, Vu Dang Luu2
1 Department of Radiology, Hanoi Medical University
2 Radiology Center, Bach Mai Hospital

Main Article Content

Abstract

Ebstein’s anomaly (EA) is a rare congenital heart disease characterized by downward displacement of the septal and inferior
tricuspid valve leaflets, redundant anterior leaflets with a sail-like morphology, and atrialization of the inlet portion of the right
ventricle. The clinical manifestations of EA are not specific and range from asymptomatic to severe as dictated by the degree
of tricuspid valve displacement, the severity of tricuspid regurgitation, effective right ventricular volume, and the presence of
associated malformations such as an atrial septal defect, arrhythmias. We report a case of a 42-year-old female patient with a history of EA diagnosed many years ago, with irregular treatment. Three months prior to admission, the patient began experiencing progressively worsening shortness of breath, leading to hospitalization at Bach Mai Hospital, where she was stabilized with medication and assessed for surgery. The echocardiogram report showed changes in the description of the morphology and attachment sites of the valve leaflets across different examinations. The patient underwent a pre-surgical cardiac magnetic resonance imaging (CMR). She was then surgically treated with the Cone technique for tricuspid valve repair. After surgery, her condition significantly improved.

Article Details

References

1. Holst KA, Connolly HM, Dearani JA. Ebstein’s Anomaly. Methodist Debakey Cardiovasc J. 2019 Apr- Jun;15(2):138-144.
2. Kumar TKS. Ebstein’s anomaly in the neonate. Indian J Thorac Cardiovasc Surg. 2021 Jan;37(Suppl 1):17-25
3. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 Apr 2. 73 (12):1494-1563.
4. Sainathan S, da Fonseca da Silva L, da Silva JP. Ebstein’s anomaly: Contemporary management strategies. Journal of Thoracic Disease. 2020;12(3):1161-1173
5. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Crumb SR, Dearani JA, Fuller S, Gurvitz M, Khairy P, Landzberg MJ, Saidi A, Valente AM, Van Hare GF. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 Apr 02;73(12):e81-e192
6. Lim ZS, Vettukattil JJ. Role of echocardiography in the assessment of adolescents and adults with congenital heart disease. Minerva Cardioangiol. 2009 Aug. 57(4):389-413.
7. Booker OJ, Nanda NC. Echocardiographic assessment of Ebstein’s anomaly. Echocardiography. 2015 Jan. 32 Suppl 2:S177-88
8. Muñoz-Castellanos L, Espinola-Zavaleta N, Kuri-Nivón M, Keirns C. Ebstein’s Anomaly: anatomo-echocardiographic correlation. Cardiovasc Ultrasound. 2007. 5:43.
9. Vettukattil JJ, Bharucha T, Anderson RH. Defining Ebstein’s malformation using three-dimensional echocardiography. Interact Cardiovasc Thorac Surg. 2007 Dec. 6(6):685-90.
10. Silva JP et al. Ebstein’s anomaly: Results of the conic reconstruction of the tricuspid valve. Arquivos Brasileiros de Cardiologia. 2004;82(3):212-216
11. Alsaied T, Castrillon CD, Christopher A, et al. Cardiac MRI predictors of right ventricular dysfunction after the Da Silva cone operation for Ebstein’s anomaly. Int J Cardiol Congenit Heart Dis. 2022. 7:100342
12. Ciepłucha A, Trojnarska O, Kociemba A, Łanocha M, Barczynski M, Rozmiarek S, Kramer L, Pyda M. Clinical aspects of myocardial fibrosis in adults with Ebstein’s anomaly. Heart Vessels. 2018 Sep;33(9):1076-1085. doi: 10.1007/s00380-018-1141-5. Epub 2018 Feb 21. PMID: 29468473; PMCID: PMC6096744.